Aier Eye Hospital Group Co. Ltd. Class A (300015)
300015 · Health Care · 
China
Aier Eye Hospital Group Co. Ltd. Class A (300015) is a company in the Health Care sector, based in China. The stock is held in 9 ETFs we track – with its largest weight of 0.03 % in XCS6 (msci-china). Anyone holding one of these ETFs also owns a small indirect stake in Aier Eye Hospital Group.
How many funds hold this stock?
Average ETF coverage: 9 of the 95 ETFs we cover hold Aier Eye Hospital Group, spread across 5 indices. That puts the stock in more ETFs than 59.1 % of the 4,334 stocks we cover.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is Aier Eye Hospital Group in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XCS6 / XCS7 | msci-china | 0.03 % | €0.30 |
| SPYI / SPSA | msci-acwi-imi | 0.00 % | €0.00 |
| SPYY | msci-acwi | 0.00 % | €0.00 |
| SPYM | msci-em | 0.00 % | €0.00 |
| IS3N | msci-em-imi | 0.00 % | €0.00 |
| XMME / XEMD | msci-em | 0.00 % | €0.00 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Aier Eye Hospital Group as of the fund's latest holdings list.
Weight in IS3N since 2019
In IS3N, a fund tracking the MSCI EM IMI, Aier Eye Hospital Group had a weight of 0.02 % on Dec 31, 2019 and 0.00 % on Sep 18, 2026. Its share peaked at 0.04 % on Jun 30, 2021. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.
How much Aier Eye Hospital Group Co. Ltd. Class A overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Aier Eye Hospital Group — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| Shenzhen Salubris Pharmaceuticals Co. Ltd. Class A | 002294 | 9 | – |
| Haisco Pharmaceutical Group Co. Ltd. Class A | 002653 | 9 | – |
| Hangzhou Tigermed Consulting Co. Ltd. Class A | 300347 | 9 | – |
| Pharmaron Beijing Co. Ltd. Class A | 300759 | 9 | – |
| CSPC Innovation Pharmaceutical Co. Ltd. Class A | 300765 | 9 | – |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A | 300832 | 9 | – |
| IMEIK Technology Development Co. Ltd. Class A | 300896 | 9 | – |
| Shanghai Fosun Pharmaceutical (Group) Co. Ltd. Class A | 600196 | 9 | – |
